Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

13 treatments under study, led by Innovative Lungprotective Ventilation Strategies

Research Leaders

8 sponsors active, led by Steve Reynolds

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2
Unknown2
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Innovative Lungprotective Ventilation Strategies1
  • Lungprotective Ventilation1
  • Negative Pressure Extubation1
  • Thoracic Surgery Without Lung Resection1
  • Voluntary With Preceding Mandatory1

Active Sponsors

  • Steve Reynolds1
  • National Taiwan University Hospital1
  • The First Hospital of Putian City, Putian, Fujian1
  • The First Affiliated Hospital of Nanchang University1
  • Fujian Medical University Union Hospital1

Top Investigators

Related Conditions

  • Acute Pulmonary Insufficiency Following Thoracic Surgery1
  • Postoperative Pulmonary Complications1
  • Atelectasis1
  • Muscle Atrophy Or Weakness1
  • Respiratory Distress Syndrome Newborn1

Activity Timeline